Newsar
Back to News

Marta Echaves, investigadora cultural de la ketamina: “Ahora las drogas se administran como fármacos y los fármacos se esnifan como drogas”

El Pais Economic ImpactNews ReportES 5 min read 100% complete by Noelia RamírezApril 3, 2026 at 05:30 AM
Marta Echaves, investigadora cultural de la ketamina: “Ahora las drogas se administran como fármacos y los fármacos se esnifan como drogas”
Read Original Article

AI Summary

long article 5 min

Marta Echaves, investigadora cultural, estudia la relación entre el consumo de sustancias, la política farmacéutica y el control de los cuerpos. Su investigación se centra ahora en la ketamina, desde su origen militar hasta su uso como antidepresivo. Echaves critica la comercialización de Spravato, un derivado de la ketamina (esketamina) utilizado como antidepresivo en forma de spray nasal, por la farmacéutica Johnson & Johnson’s. Considera que esta estrategia aísla el consumo de la sustancia de un acompañamiento terapéutico necesario y genera un beneficio económico desproporcionado. Su próximo ensayo, "Químicas piedades", explora esta trayectoria de la ketamina y estará disponible en librerías el 16 de abril.

Article Analysis

Framing Angle
Economic Impact
Primary framing
Public Health
Secondary framing
Measured
Sensationalism
Mixed
Fact vs Opinion
OpinionFactual
1
Sources Cited
Limited sources
AI-powered analysis of article framing, tone, and source quality. Scores help identify potential bias and information quality.

Key Claims (5)

AI-Extracted

In 2025, global sales of Spravato reached 350 million euros.

statistic100% confidence

Spravato costs between 500 and 700 euros, while generic ketamine costs around 50 cents.

factual — Marta Echaves100% confidence

Spravato, an antidepressant derived from ketamine, was approved in the US in 2019.

factual — Marta Echaves100% confidence

Ketamine can function as an antidepressant, but also generates bladder problems and addiction.

quote — Marta Echaves90% confidence

There is development of 'ketamine wearable' devices for pain treatment.

quote — Marta Echaves80% confidence
Claims are automatically extracted and should be independently verified. Attribution indicates the stated source of the claim.

Key Entities & Roles

Key Player Opposition Context
Gràcia 30% Caja Negra 30% Arganzuela 40% Madrid 40% Paul B. Preciado 50% Johnson & Johnson 60% Estados Unidos 70% Spravato ×480% Marta Echaves 90% ketamine ×690%

Keywords

ketamina 100% spravato 90% esketamina 80% industria farmacéutica 70% fármacos 60% drogas 60% antidepresivo 50% marta echaves 50% política farmacéutica 40%

Sentiment Analysis

Negative
Score: -0.30

Source Transparency

Source
El Pais
Article Type
News Report
Classification Confidence
90%
Geographic Perspective
Estados Unidos

This article was automatically classified using rule-based analysis.

Topic Connections

Explore how the topics in this article connect to other news stories

Network visualization showing 9 related topics
View Full Graph
ketaminaspravatoesketaminaindustria farmacéuticafármacosdrogasantidepresivomarta echavespolítica farmacéutica
Explore Full Topic Graph

Find Similar Articles

AI-Powered

Discover articles with similar content using semantic similarity analysis.